< 0 1 0 1 O
Grade 2 7 2 7 B-upper_bound
2 8 9 8 9 I-upper_bound
acute 10 15 10 15 B-clinical_variable
GVHD 16 20 16 20 I-clinical_variable
at 21 23 21 23 O
time 24 28 24 28 O
of 29 31 29 31 O
the 32 35 32 35 O
first 36 41 36 41 O
NK 42 44 42 44 B-treatment
cell 45 49 45 49 I-treatment
- 49 50 49 50 I-treatment
enriched 50 58 50 58 I-treatment
DLI 59 62 59 62 I-treatment

A 0 1 63 64 O
tubal 2 7 65 70 B-treatment
ligation 8 16 71 79 I-treatment
is 17 19 80 82 O
adequate 20 28 83 91 O
documentation 29 42 92 105 O
that 43 47 106 110 O
a 48 49 111 112 O
patient 50 57 113 120 O
is 58 60 121 123 O
not 61 64 124 127 O
of 65 67 128 130 O
child 68 73 131 136 O
bearing 74 81 137 144 O
potential 82 91 145 154 O

Age 0 3 155 158 B-age
of 4 6 159 161 O
> 7 8 162 163 O
= 8 9 163 164 O
18 10 12 165 167 B-lower_bound
years 13 18 168 173 I-lower_bound

Documented 0 10 174 184 O
adequate 11 19 185 193 O
hematologic 20 31 194 205 O
parameters 32 42 206 216 O
including 43 52 217 226 O
a 53 54 227 228 O
hematocrit 55 65 229 239 B-clinical_variable
> 66 67 240 241 O
35 68 70 242 244 B-lower_bound
% 70 71 244 245 I-lower_bound
for 72 75 246 249 O
males 76 81 250 255 B-gender
and 82 85 256 259 O
33 86 88 260 262 B-lower_bound
% 88 89 262 263 I-lower_bound
for 90 93 264 267 O
females 94 101 268 275 B-gender
, 101 102 275 276 O
white 103 108 277 282 B-clinical_variable
blood 109 114 283 288 I-clinical_variable
cell 115 119 289 293 I-clinical_variable
count 120 125 294 299 I-clinical_variable
of 126 128 300 302 O
> 129 130 303 304 O
= 130 131 304 305 O
3,000 131 136 305 310 B-lower_bound
, 136 137 310 311 O
and 138 141 312 315 O
platelets 142 151 316 325 B-clinical_variable
> 152 153 326 327 O
= 153 154 327 328 O
80,000 154 160 328 334 B-lower_bound

Documented 0 10 335 345 O
bilirubin 11 20 346 355 B-clinical_variable
and 21 24 356 359 I-clinical_variable
hepatic 25 32 360 367 I-clinical_variable
transaminases 33 46 368 381 I-clinical_variable
of 47 49 382 384 O
< 50 51 385 386 O
2.5 52 55 387 390 B-upper_bound
x 56 57 391 392 I-upper_bound
ULN 58 61 393 396 I-upper_bound

Donor 0 5 397 402 B-clinical_variable
cellular 6 14 403 411 I-clinical_variable
engraftment 15 26 412 423 I-clinical_variable
of 27 29 424 426 O
at 30 32 427 429 O
least 33 38 430 435 O
2.5 39 42 436 439 B-lower_bound
% 42 43 439 440 I-lower_bound
from 44 48 441 445 O
the 49 52 446 449 O
non 53 56 450 453 B-treatment
- 56 57 453 454 I-treatment
myeloablative 57 70 454 467 I-treatment
procedure 71 80 468 477 I-treatment

Donor 0 5 478 483 O
must 6 10 484 488 O
not 11 14 489 492 O
have 15 19 493 497 O
any 20 23 498 501 O
medical 24 31 502 509 O
condition 32 41 510 519 O
which 42 47 520 525 O
would 48 53 526 531 O
make 54 58 532 536 O
apheresis 59 68 537 546 B-treatment
more 69 73 547 551 O
than 74 78 552 556 O
a 79 80 557 558 O
minimal 81 88 559 566 O
risk 89 93 567 571 O

Donors 0 6 572 578 O
under 7 12 579 584 O
the 13 16 585 588 O
age 17 20 589 592 B-age
of 21 23 593 595 O
18 24 26 596 598 B-lower_bound
who 27 30 599 602 O
can 31 34 603 606 O
not 34 37 606 609 O
assent 38 44 610 616 O
based 45 50 617 622 O
on 51 53 623 625 O
their 54 59 626 631 O
developmental 60 73 632 645 O
stage 74 79 646 651 O
will 80 84 652 656 O
not 85 88 657 660 O
be 89 91 661 663 O
included 92 100 664 672 O

Estimated 0 9 673 682 O
survival 10 18 683 691 O
of 19 21 692 694 O
at 22 24 695 697 O
least 25 30 698 703 O
8 31 32 704 705 B-lower_bound
weeks 33 38 706 711 I-lower_bound

Family 0 6 712 718 O
members 7 14 719 726 O
will 15 19 727 731 O
be 20 22 732 734 O
considered 23 33 735 745 O
for 34 37 746 749 O
donation 38 46 750 758 O
if 47 49 759 761 O
they 50 54 762 766 O
do 55 57 767 769 O
not 58 61 770 773 O
have 62 66 774 778 O
a 67 68 779 780 O
history 69 76 781 788 O
of 77 79 789 791 O
known 80 85 792 797 O
cardiac 86 93 798 805 B-chronic_disease
problem 94 101 806 813 I-chronic_disease
and 102 105 814 817 O
do 106 108 818 820 O
not 109 112 821 824 O
have 113 117 825 829 O
abnormal 118 126 830 838 B-chronic_disease
cardiac 127 134 839 846 I-chronic_disease
findings 135 143 847 855 O
by 144 146 856 858 O
physical 147 155 859 867 O
examination 156 167 868 879 O

Females 0 7 880 887 B-gender
of 8 10 888 890 O
childbearing 11 23 891 903 O
potential 24 33 904 913 O
should 34 40 914 920 O
have 41 45 921 925 O
a 46 47 926 927 O
negative 48 56 928 936 B-pregnancy
serum 57 62 937 942 I-pregnancy
beta 63 67 943 947 I-pregnancy
- 67 68 947 948 I-pregnancy
HCG 68 71 948 951 I-pregnancy
test 72 76 952 956 O
within 77 83 957 963 O
1 84 85 964 965 B-upper_bound
week 86 90 966 970 I-upper_bound
of 91 93 971 973 O
beginning 94 103 974 983 O
apheresis 104 113 984 993 O

Females 0 7 994 1001 B-gender
of 8 10 1002 1004 O
childbearing 11 23 1005 1017 O
potential 24 33 1018 1027 O
should 34 40 1028 1034 O
have 41 45 1035 1039 O
a 46 47 1040 1041 O
negative 48 56 1042 1050 B-pregnancy
serum 57 62 1051 1056 I-pregnancy
beta 63 67 1057 1061 I-pregnancy
- 67 68 1061 1062 I-pregnancy
HCG 68 71 1062 1065 I-pregnancy
test 72 76 1066 1070 O
within 77 83 1071 1077 O
48 84 86 1078 1080 B-upper_bound
hours 87 92 1081 1086 I-upper_bound
of 93 95 1087 1089 O
beginning 96 105 1090 1099 O
DLI 106 109 1100 1103 O
and/or 110 116 1104 1110 O
DUK 117 120 1111 1114 O
- 120 121 1114 1115 O
CPG-01 121 127 1115 1121 O
unless 128 134 1122 1128 O
contraception 135 148 1129 1142 B-contraception_consent
is 149 151 1143 1145 O
used 152 156 1146 1150 O
after 157 162 1151 1156 O
initial 163 170 1157 1164 O
testing 171 178 1165 1172 O

It 0 2 1173 1175 O
is 3 5 1176 1178 O
not 6 9 1179 1182 O
anticipated 10 21 1183 1194 O
that 22 26 1195 1199 O
any 27 30 1200 1203 O
such 31 35 1204 1208 O
patients 36 44 1209 1217 O
would 45 50 1218 1223 O
be 51 53 1224 1226 O
transplanted 54 66 1227 1239 O
within 67 73 1240 1246 O
our 74 77 1247 1250 O
program 78 85 1251 1258 O
, 85 86 1258 1259 O
however 87 94 1260 1267 O
but 95 98 1268 1271 O
those 99 104 1272 1277 O
in 105 107 1278 1280 O
first 108 113 1281 1286 O
remission 114 123 1287 1296 O
AML 124 127 1297 1300 B-cancer
patients 128 136 1301 1309 O
with 137 141 1310 1314 O
good 142 146 1315 1319 O
risk 147 151 1320 1324 O
standard 152 160 1325 1333 O
genetics 161 169 1334 1342 O
or 170 172 1343 1345 O
normal 173 179 1346 1352 O
genetics 180 188 1353 1361 O
with 189 193 1362 1366 O
either 194 200 1367 1373 O
NPM1 201 205 1374 1378 O
or 206 208 1379 1381 O
CEBPA 209 214 1382 1387 O
mutations 215 224 1388 1397 O
, 224 225 1397 1398 O
first 226 231 1399 1404 O
chronic 232 239 1405 1412 O
phase 240 245 1413 1418 O
CML 246 249 1419 1422 B-cancer
without 250 257 1423 1430 O
kinase 258 264 1431 1437 O
gene 265 269 1438 1442 O
mutations 270 279 1443 1452 O
, 279 280 1452 1453 O
follicular 281 291 1454 1464 B-cancer
lymphoma 292 300 1465 1473 I-cancer
patients 301 309 1474 1482 O
in 310 312 1483 1485 O
first 313 318 1486 1491 O
remission 319 328 1492 1501 O
who 329 332 1502 1505 O
only 333 337 1506 1510 O
required 338 346 1511 1519 O
1 347 348 1520 1521 O
regimen 349 356 1522 1529 B-treatment
to 357 359 1530 1532 O
attain 360 366 1533 1539 O
remission 367 376 1540 1549 O
all 377 380 1550 1553 O
would 381 386 1554 1559 O
be 387 389 1560 1562 O
excluded 390 398 1563 1571 O
from 399 403 1572 1576 O
this 404 408 1577 1581 O
protocol 409 417 1582 1590 O

Males 0 5 1591 1596 B-gender
must 6 10 1597 1601 O
agree 11 16 1602 1607 B-contraception_consent
to 17 19 1608 1610 I-contraception_consent
use 20 23 1611 1614 I-contraception_consent
a 24 25 1615 1616 I-contraception_consent
medically 26 35 1617 1626 I-contraception_consent
acceptable 36 46 1627 1637 I-contraception_consent
form 47 51 1638 1642 I-contraception_consent
of 52 54 1643 1645 I-contraception_consent
birth 55 60 1646 1651 I-contraception_consent
control 61 68 1652 1659 I-contraception_consent
in 69 71 1660 1662 O
order 72 77 1663 1668 O
to 78 80 1669 1671 O
be 81 83 1672 1674 O
in 84 86 1675 1677 O
this 87 91 1678 1682 O
study 92 97 1683 1688 O
and 98 101 1689 1692 O
for 102 105 1693 1696 O
3 106 107 1697 1698 B-upper_bound
months 108 114 1699 1705 I-upper_bound
after 115 120 1706 1711 I-upper_bound
infusion 121 129 1712 1720 O

Patients 0 8 1721 1729 O
likely 9 15 1730 1736 O
to 16 18 1737 1739 O
have 19 23 1740 1744 O
a 24 25 1745 1746 O
significantly 26 39 1747 1760 O
better 40 46 1761 1767 O
durable 47 54 1768 1775 O
response 55 63 1776 1784 O
to 64 66 1785 1787 O
allogeneic 67 77 1788 1798 B-treatment
transplant 78 88 1799 1809 I-treatment
alone 89 94 1810 1815 O
( 95 96 1816 1817 O
better 96 102 1817 1823 O
than 103 107 1824 1828 O
60 108 110 1829 1831 O
% 110 111 1831 1832 O
progression 112 123 1833 1844 O
free 124 128 1845 1849 O
longer 129 135 1850 1856 O
than 136 140 1857 1861 O
2 141 142 1862 1863 O
years 143 148 1864 1869 O
) 148 149 1869 1870 O

Patients 0 8 1871 1879 O
with 9 13 1880 1884 O
hematologic 14 25 1885 1896 B-chronic_disease
diseases 26 34 1897 1905 I-chronic_disease
who 35 38 1906 1909 O
have 39 43 1910 1914 O
undergone 44 53 1915 1924 O
T 54 55 1925 1926 B-treatment
- 55 56 1926 1927 I-treatment
cell 56 60 1927 1931 I-treatment
depleted 61 69 1932 1940 I-treatment
reduced 70 77 1941 1948 I-treatment
intensity 78 87 1949 1958 I-treatment
or 88 90 1959 1961 O
non 91 94 1962 1965 B-treatment
- 94 95 1965 1966 I-treatment
ablative 95 103 1966 1974 I-treatment
allogeneic 104 114 1975 1985 I-treatment
transplantation 115 130 1986 2001 I-treatment
, 130 131 2001 2002 O
using 132 137 2003 2008 O
a 138 139 2009 2010 O
7 140 141 2011 2012 O
- 141 142 2012 2013 O
8/8 142 145 2013 2016 O
HLA 146 149 2017 2020 O
- 149 150 2020 2021 O
matched 150 157 2021 2028 O
related 158 165 2029 2036 O
or 166 168 2037 2039 O
unrelated 169 178 2040 2049 O
donor 179 184 2050 2055 O
or 185 187 2056 2058 O
4 188 189 2059 2060 O
- 189 190 2060 2061 O
6/8 190 193 2061 2064 O
HLA 194 197 2065 2068 O
- 197 198 2068 2069 O
matched 198 205 2069 2076 O
related 206 213 2077 2084 O
donor 214 219 2085 2090 O

Patients 0 8 2091 2099 O
with 9 13 2100 2104 O
other 14 19 2105 2110 O
major 20 25 2111 2116 O
medical 26 33 2117 2124 B-chronic_disease
or 34 36 2125 2127 O
psychiatric 37 48 2128 2139 B-chronic_disease
illnesses 49 58 2140 2149 I-chronic_disease
, 58 59 2149 2150 O
which 60 65 2151 2156 O
the 66 69 2157 2160 O
treating 70 78 2161 2169 O
physician 79 88 2170 2179 O
feels 89 94 2180 2185 O
, 94 95 2185 2186 O
could 96 101 2187 2192 O
seriously 102 111 2193 2202 O
compromise 112 122 2203 2213 O
tolerance 123 132 2214 2223 O
to 133 135 2224 2226 O
this 136 140 2227 2231 O
protocol 141 149 2232 2240 O

Patients 0 8 2241 2249 O
with 9 13 2250 2254 O
treated 14 21 2255 2262 O
acute 22 27 2263 2268 O
GVHD 28 32 2269 2273 B-chronic_disease
must 33 37 2274 2278 O
be 38 40 2279 2281 O
on 41 43 2282 2284 O
a 44 45 2285 2286 O
stable 46 52 2287 2293 O
dose 53 57 2294 2298 O
of 58 60 2299 2301 O
therapy 61 68 2302 2309 B-treatment
( 69 70 2310 2311 O
no 70 72 2311 2313 O
increase 73 81 2314 2322 O
in 82 84 2323 2325 O
immunosuppressive 85 102 2326 2343 B-treatment
therapy 103 110 2344 2351 I-treatment
for 111 114 2352 2355 O
the 115 118 2356 2359 O
2 119 120 2360 2361 B-upper_bound
weeks 121 126 2362 2367 I-upper_bound
before 127 133 2368 2374 I-upper_bound
planned 134 141 2375 2382 O
NK 142 144 2383 2385 O
cell 145 149 2386 2390 O
- 149 150 2390 2391 O
enriched 150 158 2391 2399 O
DLIs 159 163 2400 2404 O
) 163 164 2404 2405 O

Performance 0 11 2406 2417 O
status 12 18 2418 2424 O
must 19 23 2425 2429 O
be 24 26 2430 2432 O
ECOG 27 31 2433 2437 B-clinical_variable
PS 32 34 2438 2440 I-clinical_variable
0 35 36 2441 2442 B-lower_bound
, 36 37 2442 2443 O
1 38 39 2444 2445 O
, 39 40 2445 2446 O
or 41 43 2447 2449 O
2 44 45 2450 2451 B-upper_bound

Potential 0 9 2452 2461 O
donors 10 16 2462 2468 O
under 17 22 2469 2474 O
the 23 26 2475 2478 O
age 27 30 2479 2482 B-age
of 31 33 2483 2485 O
18 34 36 2486 2488 B-lower_bound
must 37 41 2489 2493 O
have 42 46 2494 2498 O
a 47 48 2499 2500 O
' 49 50 2501 2502 O
single 50 56 2502 2508 O
patient 57 64 2509 2516 O
exemption 65 74 2517 2526 O
' 74 75 2526 2527 O
approved 76 84 2528 2536 O
by 85 87 2537 2539 O
the 88 91 2540 2543 O
IRB 92 95 2544 2547 O

Pregnant 0 8 2548 2556 B-pregnancy
or 9 11 2557 2559 O
lactating 12 21 2560 2569 O
women 22 27 2570 2575 B-gender

The 0 3 2576 2579 O
dosage 4 10 2580 2586 O
/ 10 11 2586 2587 O
level 11 16 2587 2592 O
of 17 19 2593 2595 O
immunosuppressive 20 37 2596 2613 B-treatment
therapy 38 45 2614 2621 I-treatment
at 46 48 2622 2624 O
the 49 52 2625 2628 O
time 53 57 2629 2633 O
of 58 60 2634 2636 O
NK 61 63 2637 2639 O
- 63 64 2639 2640 O
DLIs 64 68 2640 2644 O
should 69 75 2645 2651 O
be 76 78 2652 2654 O
no 79 81 2655 2657 O
greater 82 89 2658 2665 O
than 90 94 2666 2670 O
20 95 97 2671 2673 B-upper_bound
mg 98 100 2674 2676 I-upper_bound
of 101 103 2677 2679 O
prednisone 104 114 2680 2690 B-treatment
daily 115 120 2691 2696 O
or 121 123 2697 2699 O
mycophenolate 124 137 2700 2713 B-treatment
500 138 141 2714 2717 B-upper_bound
mg 142 144 2718 2720 I-upper_bound
bid 145 148 2721 2724 O
daily 149 154 2725 2730 O
or 155 157 2731 2733 O
cyclosporine 158 170 2734 2746 B-treatment
with 171 175 2747 2751 O
a 176 177 2752 2753 O
target 178 184 2754 2760 O
level 185 190 2761 2766 O
of 191 193 2767 2769 O
200 194 197 2770 2773 B-upper_bound
ng 198 200 2774 2776 I-upper_bound
/ 200 201 2776 2777 I-upper_bound
mL 201 203 2777 2779 I-upper_bound
or 204 206 2780 2782 O
tacrolimus 207 217 2783 2793 B-treatment
with 218 222 2794 2798 O
a 223 224 2799 2800 O
target 225 231 2801 2807 O
level 232 237 2808 2813 O
of 238 240 2814 2816 O
10 241 243 2817 2819 B-upper_bound
ng 244 246 2820 2822 I-upper_bound
/ 246 247 2822 2823 I-upper_bound
mL 247 249 2823 2825 I-upper_bound

This 0 4 2826 2830 O
may 5 8 2831 2834 O
include 9 16 2835 2842 O
patients 17 25 2843 2851 O
with 26 30 2852 2856 O
a 31 32 2857 2858 O
mixed 33 38 2859 2864 B-chronic_disease
chimeric 39 47 2865 2873 I-chronic_disease
state 48 53 2874 2879 I-chronic_disease
or 54 56 2880 2882 O
disease 57 64 2883 2890 O
persistence 65 76 2891 2902 O
or 77 79 2903 2905 O
at 80 82 2906 2908 O
high 83 87 2909 2913 O
risk 88 92 2914 2918 O
of 93 95 2919 2921 O
relapse 96 103 2922 2929 O

Those 0 5 2930 2935 O
with 6 10 2936 2940 O
a 11 12 2941 2942 O
history 13 20 2943 2950 O
of 21 23 2951 2953 O
cardiac 24 31 2954 2961 B-chronic_disease
problems 32 40 2962 2970 I-chronic_disease
or 41 43 2971 2973 O
abnormal 44 52 2974 2982 O
cardiac 53 60 2983 2990 O
findings 61 69 2991 2999 O
by 70 72 3000 3002 O
physical 73 81 3003 3011 O
examination 82 93 3012 3023 O
should 94 100 3024 3030 O
undergo 101 108 3031 3038 O
a 109 110 3039 3040 O
stress 111 117 3041 3047 O
evaluation 118 128 3048 3058 O
or 129 131 3059 3061 O
be 132 134 3062 3064 O
evaluated 135 144 3065 3074 O
by 145 147 3075 3077 O
a 148 149 3078 3079 O
cardiologist 150 162 3080 3092 O
and 163 166 3093 3096 O
deemed 167 173 3097 3103 O
eligible 174 182 3104 3112 O
to 183 185 3113 3115 O
donate 186 192 3116 3122 O

has 0 3 3123 3126 O
not 4 7 3127 3130 O
been 8 12 3131 3135 O
naturally 13 22 3136 3145 O
postmenopausal 23 37 3146 3160 O
for 38 41 3161 3164 O
at 42 44 3165 3167 O
least 45 50 3168 3173 O
24 51 53 3174 3176 B-lower_bound
consecutive 54 65 3177 3188 I-lower_bound
months 66 72 3189 3195 I-lower_bound
( 73 74 3196 3197 O
i.e. 74 78 3197 3201 O
, 78 79 3201 3202 O
has 80 83 3203 3206 O
had 84 87 3207 3210 O
menses 88 94 3211 3217 O
at 95 97 3218 3220 O
any 98 101 3221 3224 O
time 102 106 3225 3229 O
in 107 109 3230 3232 O
the 110 113 3233 3236 O
preceding 114 123 3237 3246 B-upper_bound
24 124 126 3247 3249 I-upper_bound
consecutive 127 138 3250 3261 I-upper_bound
months 139 145 3262 3268 I-upper_bound
) 145 146 3268 3269 O

the 0 3 3270 3273 O
FACT 4 8 3274 3278 O
labs 9 13 3279 3283 O
must 14 18 3284 3288 O
be 19 21 3289 3291 O
redrawn 22 29 3292 3299 O
within 30 36 3300 3306 O
30 37 39 3307 3309 B-upper_bound
days 40 44 3310 3314 I-upper_bound
of 45 47 3315 3317 O
initiation 48 58 3318 3328 O
of 59 61 3329 3331 O
apheresis 62 71 3332 3341 B-treatment

those 0 5 3342 3347 O
with 6 10 3348 3352 O
myeloproliferative 11 29 3353 3371 B-cancer
diseases 30 38 3372 3380 I-cancer
or 39 41 3381 3383 O
hemoglobinopathies 42 60 3384 3402 B-chronic_disease
with 61 65 3403 3407 O
over 66 70 3408 3412 O
50 71 73 3413 3415 B-lower_bound
% 73 74 3415 3416 I-lower_bound
T 75 76 3417 3418 B-clinical_variable
cell 77 81 3419 3423 I-clinical_variable
subset 82 88 3424 3430 I-clinical_variable
engraftment 89 100 3431 3442 I-clinical_variable
( 101 102 3443 3444 O
assessed 102 110 3444 3452 O
around 111 117 3453 3459 O
100 118 121 3460 3463 O
days 122 126 3464 3468 O
post 127 131 3469 3473 B-treatment
transplant 132 142 3474 3484 I-treatment
) 142 143 3484 3485 O

